Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 2/20 | 0.42 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.42 |
| ▸ | GCGR | P47871 | 2/20 | 0.41 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.39 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.38 |
| ▸ | DHFR | P00374 | 1/20 | 0.38 |
| ▸ | HEXA | P06865 | 1/20 | 0.38 |
| ▸ | HEXB | P07686 | 1/20 | 0.38 |
| ▸ | USP7 | Q93009 | 3/20 | 0.37 |
| ▸ | TP53 | P04637 | 2/20 | 0.37 |
| ▸ | LMNA | P02545 | 2/20 | 0.36 |
| ▸ | MAPT | P10636 | 2/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | NPC1 | O15118 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7711087 | 0.81 | ALDH1A1 (0.50) | ESR1ESR2DHFRLMNAMAPT | |
| SCHEMBL28837822 | 0.79 | USP7 (0.42) | ESR1ESR2GCGRPTGS1PTGS2 | |
| SCHEMBL3960905 | 0.78 | ALDH1A1 (0.37) | DHFRLMNAMAPTHTTALDH1A1 | |
| SCHEMBL14182621 | 0.78 | LMNA (0.48) | ESR1ESR2DHFRLMNAMAPT | |
| SCHEMBL247368 | 0.78 | LMNA (0.48) | ESR1ESR2DHFRLMNAMAPT | |
| SCHEMBL27860186 | 0.77 | ESR1 (0.47) | ESR1ESR2GCGRPTGS1PTGS2 | |
| SCHEMBL7704707 | 0.76 | LMNA (0.46) | ESR1ESR2DHFRLMNAMAPT | |
| SCHEMBL1179753 | 0.75 | ALDH1A1 (0.50) | ESR1ESR2DHFRLMNAMAPT | |
| SCHEMBL13026660 | 0.75 | — | — | |
| SCHEMBL10880447 | 0.75 | GCGR (0.39) | GCGRDHFRLMNAMAPTHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7902363-B2 | Novel air stable and solution processable n-type compounds such as n,n'-bis[3,7-dimethyl-6-octenyl]-1,7-dicyanoperylene-3,4:9,10-bis(dicarboxiamide); complementary circuits, organic light emitting diodes and photovoltaics, capacitors, sensors | POLYERA CORPORATION (US) | 2011-03-08 | — | — | US | disclosed |
| US-7893265-B2 | Imidation of derivatives of anthracene-2,3:6,7-dianhydride, napthalene-1,4:5,8-dianhydride, or perylene-3,4:9,10-anhydride with primary amine to perylene-bis(dicarboximide)s, naphthalene-bis(dicarboximide)s, and anthracene-bis(dicarboximide)s and/or coronene-bis(dicarboximide)s; electronics, composites | POLYERA CORPORATION (US) | 2011-02-22 | — | — | US | disclosed |
| US-20080185577-A1 | Diimide-based semiconductor materials and methods of preparing and using the same | USINVEST LLC | 2008-08-07 | — | — | US | disclosed |
| US-20080177073-A1 | Methods for preparing arene-BIS (dicarboximide)-based semiconducting materials and related intermediates for preparing same | USINVEST LLC | 2008-07-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080177073-A1 | Methods for preparing arene-BIS (dicarboximide)-based semiconducting materials and related intermediates for preparing same | RECQL, CCNE2, CCNE1 | ESR1 635/4885ESR2 1530/4885GCGR 3920/4885 |
| US-20080185577-A1 | Diimide-based semiconductor materials and methods of preparing and using the same | DDT, INMT, PIR | ESR1 1279/4885ESR2 2742/4885GCGR 4554/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.